IL-15 增强间皮素和 CD70 CAR NK 细胞在 PDAC 中的效力,双靶向未带来额外获益
IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting.
77.2分
★★★★☆
站内排序·非疗效
FRONTIER PAPERS
IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting.
Sequential Targeting Hybrid Nanovesicles Composed of Chimeric Antigen Receptor T-Cell-Derived Exosomes and Liposomes for Enhanced Cancer Immunochemoth
Advancements in CAR-T Cell Therapy for Ovarian Cancer: Current Strategies and Future Directions.
Design and development of dual targeting CAR protein for the development of CAR T-cell therapy against KRAS mutated pancreatic ductal adenocarcinoma u
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。